This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
First round gives cancer metabolism start-up Agios $33mm
09 Jul 2008
Agios Pharmaceuticals (developing drug candidates that affect cancer metabolism) sold $33mm of common stock in its Series A financing, which was co-led by Third Rock Ventures and returning seed investors Flagship Ventures and Arch Venture Partners.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?